M. Sekip Altunkan: Can Anticoagulation Be Safely Stopped After AF Ablation?
M. Sekip Altunkan, Associate Professor and Internal Medicine Specialist at a Private Medical Practice, shared a post on LinkedIn:
“Retiring the Blood Thinner: ALONE-AF Reassesses Anticoagulation After Successful Ablation
If catheter ablation successfully silences atrial fibrillation without recurrence, must patients still swallow a blood thinner every single morning?
A post-hoc analysis of the randomized ALONE-AF trial in Heart Rhythm reveals that discontinuing oral anticoagulants did not increase stroke or systemic embolism rates, even among individuals categorized as high-risk by CHA2DS2-VASc scoring.
With all major bleeding events occurring exclusively in patients who continued therapy, this milestone challenges lifelong empiric anticoagulation in favor of personalized, surveillance-guided cessation.
Read the full clinical evaluation, left atrial mechanical recovery dynamics, and post-ablation decision pathways on VitalsDaily.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 02:26Ahmed Ammar: Managing VT Recurrence Post-Ablation
-
Oct 20, 2026, 01:43Oliver Weingärtner: Deprescribing of Lipid Lowering Drug after MI is Associated with Cardiovascular Events
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring